In vitro experiments rescuing intact EZH2, on the other hand, can restore the hematopoietic defects induced by mutant SRSF2, suggesting the crosstalk of compound mutations of different groups of genes in MDS pathogenesis [104]. Here, SRSF2 is linked to myelodysplastic syndrome.